TXMD
TherapeuticsMD, Inc. (TXMD) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
TXMD shows limited disclosed environmental intensity data, which makes peer benchmarking difficult and leaves its relative footprint less transparent than better-disclosed healthcare peers.
The company’s low leverage does not materially improve environmental positioning, but it can reduce financing pressure that often constrains peers’ sustainability investments.
No material environmental controversies or transition-risk disclosures were provided, so the assessment remains neutral rather than advantaged versus peers.
Compared with larger healthcare peers that publish more detailed emissions and resource-use metrics, TXMD appears less mature in environmental disclosure and oversight.
Social
TXMD’s business model is not inherently labor- or safety-intensive, which lowers direct social exposure relative to manufacturing-heavy peers.
The absence of provided workforce, product-safety, or patient-outcome metrics limits evidence of stronger social management versus more transparent peers.
High gross margin can support investment in product quality and customer support, but the metric alone does not demonstrate superior social performance.
Relative to peers with established reporting on diversity, training, and product stewardship, TXMD’s social positioning appears average due to limited disclosure depth.
Governance
TXMD’s low debt-to-equity ratio suggests comparatively restrained balance-sheet risk, which can support governance discipline versus more levered peers.
Zero reported stock-based compensation to revenue indicates limited dilution pressure, a positive signal relative to peers with heavier equity-based pay structures.
The provided data do not show board independence, audit quality, or shareholder-rights metrics, so governance strength cannot be confirmed beyond capital discipline.
Compared with peers that disclose broader governance controls, TXMD appears moderately positioned because financial discipline is visible while formal oversight disclosure remains limited.
Overall Score
TXMD’s ESG profile is broadly average versus peers, with modest governance discipline offset by limited disclosure across environmental and social dimensions.
Score Driver: Limited ESG Disclosure Depth Relative To Peers
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on TherapeuticsMD, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
